57 /100
HIGH RISK
Score updated Jul 13, 2026

JSPR — Jasper Therapeutics, Inc. Dilution Risk Tracker

Track JSPR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track JSPR — Get alerts when the score changes →

As of July 13, 2026, Jasper Therapeutics, Inc. (JSPR) has a DilutionWatch DilutionScore of 57/100, rated HIGH dilution risk. Jasper Therapeutics, Inc. has a market capitalization of $23.21M, 28.00M shares outstanding, 65 institutional holders tracked. Key dilution vectors include approximately 3 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
85
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
45%
🔄 Reverse Split 70%
• 50-day avg $0.93 below $1 exchange minimum
• Only 3 months cash — financial pressure
💰 Capital Raise 35%
• Low cash runway: 3 months remaining
🔔 Track JSPR — Get forecast alerts →

💹 Market Data

Market Cap$23.21M
Shares Outstanding28.00M
Float21.88M
Cash$17.54M
Debt$757.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 7.5% shares (2026Q1 vs prior)
65 institutional holders · 21.76M shares
#1 MORGAN STANLEY 4.09M shares
#2 Velan Capital Investment Management LP 2.67M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.35M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.70M
Days to Cover2.7
% of Float7.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for JSPR Shareholders

Jasper Therapeutics, Inc. (JSPR) has a DilutionScore of 57/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: JSPR has approximately 3 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for JSPR in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for JSPR alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track JSPR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking JSPR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for JSPR
📊 JSPR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 JSPR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.